home / stock / adk:cc / adk:cc news

ADK:CC News and Press, Diagnos Inc. From 11/25/25

Stock Information
Company Name: Diagnos Inc.
Stock Symbol: ADK:CC
Market: TSXVC
Website: diagnos.ca
Menu
ADK:CC ADK:CC Quote ADK:CC Short ADK:CC News ADK:CC Articles ADK:CC Message Board
Get ADK:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
ADK:CC - Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Québec, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSXV: ADK and OTCQB: DGNOF) is pleased to announce t...
ADK:CC - DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announ...

ADK:CC - DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital

Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Quebec, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSXV: ADK and OTCQB: DGNOF) is pleased to announce th...

ADK:CC - DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors

BROSSARD, Quebec, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announ...
ADK:CC - DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board

BROSSARD, Quebec, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence ( AI ), ...

ADK:CC - DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025

BROSSARD, Quebec, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announ...

ADK:CC - DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit

Brossard, Quebec--(Newsfile Corp. - October 15, 2025) - Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) ("DIAGNOS" or the "Corporation"), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), is pleased to announce it will...
ADK:CC - Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA

BROSSARD, Quebec, Oct. 08, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence ( AI ), ...

ADK:CC - DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence ( AI ),...

ADK:CC - DIAGNOS Announces Private Placement

BROSSARD, Quebec, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence ( AI ),...
Previous 10 Next 10